Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$7.03 - $11.07 $5,778 - $9,099
-822 Reduced 17.09%
3,989 $29,000
Q3 2023

Nov 14, 2023

BUY
$6.92 - $9.31 $6,975 - $9,384
1,008 Added 26.51%
4,811 $37,000
Q2 2023

Aug 10, 2023

BUY
$6.36 - $11.47 $4,324 - $7,799
680 Added 21.77%
3,803 $31,000
Q1 2023

May 15, 2023

SELL
$7.03 - $11.53 $10,130 - $16,614
-1,441 Reduced 31.57%
3,123 $22,000
Q4 2022

Jun 14, 2023

BUY
$8.32 - $13.21 $11,989 - $19,035
1,441 Added 46.14%
4,564 $40.5 Million
Q3 2022

Jun 14, 2023

BUY
$12.16 - $19.42 $17,522 - $27,984
1,441 Added 46.14%
4,564 $55.9 Million
Q2 2022

Jun 20, 2023

BUY
$9.99 - $21.35 $14,395 - $30,765
1,441 Added 46.14%
4,564 $53,000
Q1 2022

Jun 20, 2023

BUY
$14.08 - $27.63 $20,289 - $39,814
1,441 Added 46.14%
4,564 $86,000
Q1 2022

Mar 30, 2023

SELL
$14.08 - $27.63 $190,727 - $374,275
-13,546 Reduced 74.8%
4,564 $86,000
Q1 2022

May 12, 2022

SELL
$14.08 - $27.63 $190,727 - $374,275
-13,546 Reduced 74.8%
4,564 $87,000
Q4 2021

Jun 21, 2023

BUY
$26.55 - $40.57 $397,904 - $608,022
14,987 Added 479.89%
18,110 $480,000
Q3 2021

Jun 21, 2023

BUY
$39.27 - $72.94 $588,539 - $1.09 Million
14,987 Added 479.89%
18,110 $743,000
Q3 2021

Mar 30, 2023

SELL
$39.27 - $72.94 $45,042 - $83,662
-1,147 Reduced 5.96%
18,110 $743,000
Q3 2021

Nov 15, 2021

SELL
$39.27 - $72.94 $45,042 - $83,662
-1,147 Reduced 5.96%
18,110 $744,000
Q2 2021

Jun 21, 2023

BUY
$31.29 - $56.64 $504,832 - $913,829
16,134 Added 516.62%
19,257 $1.09 Million
Q2 2021

Mar 30, 2023

BUY
$31.29 - $56.64 $33,918 - $61,397
1,084 Added 5.96%
19,257 $1.09 Million
Q2 2021

Aug 16, 2021

BUY
$31.29 - $56.64 $601,988 - $1.09 Million
19,239 Added 106883.33%
19,257 $1.09 Million
Q1 2021

Jun 26, 2023

BUY
$39.71 - $90.58 $597,635 - $1.36 Million
15,050 Added 481.91%
18,173 $763 Million
Q1 2021

Mar 30, 2023

BUY
$39.71 - $90.58 $32,165 - $73,369
810 Added 4.67%
18,173 $763,000
Q1 2021

May 14, 2021

SELL
$39.71 - $90.58 $688,769 - $1.57 Million
-17,345 Reduced 99.9%
18 $763,000
Q4 2020

Jun 22, 2023

BUY
$27.07 - $84.35 $385,476 - $1.2 Million
14,240 Added 455.97%
17,363 $1.22 Million
Q4 2020

Mar 30, 2023

SELL
$27.07 - $84.35 $25,608 - $79,795
-946 Reduced 5.17%
17,363 $1.22 Million
Q4 2020

Feb 16, 2021

SELL
$27.07 - $84.35 $25,608 - $79,795
-946 Reduced 5.17%
17,363 $1.22 Million
Q3 2020

Jun 26, 2023

BUY
$28.06 - $37.16 $426,119 - $564,311
15,186 Added 486.26%
18,309 $513,000
Q3 2020

Mar 30, 2023

BUY
$28.06 - $37.16 $48,656 - $64,435
1,734 Added 10.46%
18,309 $513,000
Q3 2020

Nov 13, 2020

BUY
$28.06 - $37.16 $48,656 - $64,435
1,734 Added 10.46%
18,309 $514,000
Q2 2020

Jun 26, 2023

BUY
$18.5 - $34.34 $248,862 - $461,941
13,452 Added 430.74%
16,575 $490,000
Q1 2020

Jul 12, 2023

BUY
$14.88 - $32.78 $200,165 - $440,956
13,452 Added 430.74%
16,575 $328,000
Q4 2019

Jul 12, 2023

BUY
$19.49 - $32.63 $262,179 - $438,938
13,452 Added 430.74%
16,575 $490,000
Q3 2019

Jul 12, 2023

BUY
$22.49 - $26.81 $302,535 - $360,648
13,452 Added 430.74%
16,575 $376,000
Q3 2019

Mar 30, 2023

BUY
$22.49 - $26.81 $36,636 - $43,673
1,629 Added 10.9%
16,575 $376,000
Q3 2019

Nov 14, 2019

BUY
$22.49 - $26.81 $36,636 - $43,673
1,629 Added 10.9%
16,575 $377,000
Q2 2019

Jul 12, 2023

BUY
$20.48 - $27.76 $249,139 - $337,700
12,165 Added 389.53%
15,288 $378,000
Q1 2019

Jul 13, 2023

BUY
$19.43 - $26.41 $229,720 - $312,245
11,823 Added 378.58%
14,946 $365,000
Q1 2019

Mar 30, 2023

BUY
$19.43 - $26.41 $201,722 - $274,188
10,382 Added 227.48%
14,946 $365,000
Q1 2019

May 16, 2019

BUY
$19.43 - $26.41 $195,193 - $265,314
10,046 Added 205.02%
14,946 $365,000
Q1 2019

May 15, 2019

SELL
$19.43 - $26.41 $195,193 - $265,314
-10,046 Reduced 67.22%
4,900 $93,000
Q4 2018

Jul 13, 2023

BUY
$18.19 - $31.79 $215,060 - $375,853
11,823 Added 378.58%
14,946 $340,000
Q4 2018

Feb 14, 2019

BUY
$18.19 - $31.79 $212,331 - $371,084
11,673 Added 356.65%
14,946 $340,000
Q3 2018

Jul 13, 2023

BUY
$27.65 - $38.39 $326,905 - $453,884
11,823 Added 378.58%
14,946 $476 Million
Q3 2018

Nov 14, 2018

SELL
$27.65 - $38.39 $322,758 - $448,126
-11,673 Reduced 78.1%
3,273 $104,000
Q2 2018

Aug 15, 2018

BUY
$31.4 - $41.01 $100,228 - $130,903
3,192 Added 27.16%
14,946 $0
Q4 2017

Feb 15, 2018

SELL
$21.89 - $31.34 $268,108 - $383,852
-12,248 Reduced 51.03%
11,754 $361,000
Q2 2017

Aug 14, 2017

BUY
N/A
24,002
24,002 $403,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.